Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH

Author: Kimura Yuki   Hyogo Hideyuki   Yamagishi Sho-ichi   Takeuchi Masayoshi   Ishitobi Tomokazu   Nabeshima Yoshitaka   Arihiro Koji   Chayama Kazuaki  

Publisher: Springer Publishing Company

ISSN: 0944-1174

Source: Journal of Gastroenterology, Vol.45, Iss.7, 2010-07, pp. : 750-757

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content